1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 21, 2025, Live Nation entered an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent, which replaces its credit agreement dated May 6, 2010. The new package includes revolving facilities, a delayed draw term loan A, and a $1.3 billion term loan B that was fully drawn at closing, with proceeds used to refinance obligations under the existing agreement. The debt is secured by substantially all of the company's and guarantor subsidiaries' personal property and carries a maximum net debt to EBITDA covenant.
Term loan B of $1.3 billion, fully drawn at closing, matures October 21, 2032, at Term SOFR plus 2.00%
New multicurrency revolver of $1.3 billion and venue expansion revolver of $400 million mature October 21, 2030
Delayed draw term loan A of $700 million; commitments expire October 21, 2027 unless drawn
Net debt to EBITDA covenant steps down from 6.75x to 5.25x, with first measurement after the quarter ended March 31, 2026
FTI Consulting reported third-quarter 2025 revenues of $956.2 million, up 3.3% from $926.0 million, and diluted EPS of $2.60 versus $1.85 a year earlier. It raised its full-year 2025 EPS guidance to $7.62 to $8.12 from $7.24 to $7.84, and on October 21, 2025 its board authorized an additional $500.0 million for share repurchases. Operating cash flow was negative $207.6 million for the first nine months of 2025, compared with positive $79.8 million a year earlier.
Q3 2025 revenues were $956.2 million, up $30.1 million, or 3.3%; net income was $82.8 million versus $66.5 million.
Diluted EPS was $2.60 versus $1.85; Economic Consulting revenues fell 22.0% to $173.1 million.
Full-year 2025 EPS guidance was raised to $7.62 to $8.12 from $7.24 to $7.84; revenue guidance is $3.685 billion to $3.735 billion.
The board added $500.0 million to the buyback program on October 21, 2025, leaving about $500.0 million available; total repurchases since 2016 cost about $1.7 billion.
Integer Holdings appointed Payman Khales as President and Chief Executive Officer and as a director, both effective October 24, 2025, as part of a transition first announced in April 2025. Joseph Dziedzic, the former CEO, will serve as a Special Advisor through March 31, 2026, and Khales' employment agreement sets his base salary at $875,000 and his target short-term bonus at 100% of base salary.
Payman Khales becomes President and CEO and joins the Board effective October 24, 2025; he previously served as Chief Operating Officer.
Khales' annual base salary rate is $875,000, with a target short-term cash bonus of 100% of base salary.
His 2026 long-term incentive award target will not be less than $5,000,000, and he receives a special restricted stock unit grant with a grant date fair value of $550,000.
Dziedzic will serve as a Special Advisor until March 31, 2026, to assist with transition matters.
Gentex reported third-quarter 2025 results on October 24, 2025. Consolidated net sales rose 8% to $655.2 million, including $84.9 million from the VOXX acquisition, while core Gentex sales fell 6% to $570.3 million. Net income attributable to Gentex fell to $101.0 million, or $0.46 per diluted share, from $122.5 million a year earlier, when a $14.9 million one-time gain on the original VOXX investment boosted results. The company also changed its 2025 guidance, narrowing full-year consolidated revenue to $2.50 to $2.60 billion.
Consolidated net sales of $655.2 million vs. $608.5 million in Q3 2024; core Gentex net sales of $570.3 million, down 6%
Net income attributable to Gentex of $101.0 million vs. $122.5 million; diluted EPS of $0.46 vs. $0.53, with the prior-year period including a $14.9 million VOXX investment gain
Core Gentex gross margin of 34.9%, up 140 basis points; tariffs reduced margins by about 90 basis points
2025 consolidated revenue guidance now $2.50 to $2.60 billion (previously $2.44 to $2.61 billion); Gentex China revenue guidance raised to $135 to $145 million
HCA Healthcare reported third-quarter 2025 revenue of $19.161 billion, up 9.6%, and net income attributable to HCA of $1.643 billion, or $6.96 per diluted share, compared with $4.88 a year earlier. The company raised its 2025 diluted EPS guidance to $27.00 to $28.00 per share, from $25.50 to $27.00, and declared a $0.72 quarterly dividend.
Q3 2025 revenue was $19.161 billion, up from $17.487 billion; diluted EPS was $6.96 versus $4.88.
Revised 2025 diluted EPS guidance is $27.00 to $28.00, up from $25.50 to $27.00 set on July 25, 2025.
Revised 2025 Adjusted EBITDA guidance is $15.250 billion to $15.650 billion, up from $14.700 billion to $15.300 billion.
Quarterly dividend of $0.72 per share is payable December 29, 2025, to holders of record on December 15, 2025.
Booz Allen Hamilton reported fiscal second-quarter 2026 results for the quarter ended September 30, 2025, with revenue down 8.1 percent to $2.9 billion and adjusted diluted EPS of $1.49, down 17.7 percent. The company lowered its full-year fiscal 2026 guidance and attributed the weaker results to a continued funding slowdown, which shareholders will weigh against the record $40 billion backlog.
Q2 net income was $175 million, down 55.1 percent; adjusted diluted EPS was $1.49, down 17.7 percent
Fiscal 2026 revenue guidance cut to $11.3 billion to $11.5 billion from $12.0 billion to $12.5 billion
Fiscal 2026 adjusted diluted EPS guidance lowered to $5.45 to $5.65 from $6.20 to $6.55
Total backlog reached a record $40 billion, up 2.9 percent; quarterly dividend of $0.55 per share is payable December 2, 2025
Lindsay Corporation disclosed that Chief Financial Officer Brian Ketcham is retiring at the end of the calendar year, and that Sam Hinrichsen will start as Senior Vice President on November 3, 2025 and succeed him as CFO upon his retirement. The filing also reports that the Committee adopted the fiscal 2026 Management Incentive Plan, which sets bonus targets and ties awards largely to company financial goals.
Brian Ketcham, Senior Vice President and CFO, is retiring at the end of the calendar year and is not a 2026 MIP participant.
Sam Hinrichsen joins as Senior Vice President on November 3, 2025 and will succeed Ketcham as CFO upon his retirement.
2026 MIP covers fiscal year ending August 31, 2026; awards range from 0% to 200% of target bonus, weighted 80% company financial performance and 20% individual performance.
Financial performance goals are fiscal 2026 revenue, operating margin percentage, and free cash flow, keyed to the fiscal 2026 operating budget.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.